-
1
-
-
37349040358
-
Interspecies interactions within oral microbial communities
-
DOI 10.1128/MMBR.00024-07
-
Kuramitsu HK, He X, Lux R, Anderson MH, Shi W. Interspecies interactions within oral microbial communities. Microbiol Mol Biol Rev 2007;71:653-70 (Pubitemid 350309182)
-
(2007)
Microbiology and Molecular Biology Reviews
, vol.71
, Issue.4
, pp. 653-670
-
-
Kuramitsu, H.K.1
He, X.2
Lux, R.3
Anderson, M.H.4
Shi, W.5
-
2
-
-
80955180995
-
Intestinal microbiota in human health and disease: The impact of probiotics
-
Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr 2011;6:209-40
-
(2011)
Genes Nutr
, vol.6
, pp. 209-240
-
-
Gerritsen, J.1
Smidt, H.2
Rijkers, G.T.3
De Vos, W.M.4
-
3
-
-
33748415364
-
Factors influencing the composition of the intestinal microbiota in early infancy
-
DOI 10.1542/peds.2005-2824
-
Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118:511-21 (Pubitemid 46085405)
-
(2006)
Pediatrics
, vol.118
, Issue.2
, pp. 511-521
-
-
Penders, J.1
Thijs, C.2
Vink, C.3
Stelma, F.F.4
Snijders, B.5
Kummeling, I.6
Van Den Brandt, P.A.7
Stobberingh, E.E.8
-
4
-
-
84857039557
-
The intestinal microbiota in health and disease
-
Young VB. The intestinal microbiota in health and disease. Curr Opin Gastroenterol 2011;28:63-9
-
(2011)
Curr Opin Gastroenterol
, vol.28
, pp. 63-69
-
-
Young, V.B.1
-
5
-
-
35348968286
-
The Human Microbiome Project
-
DOI 10.1038/nature06244, PII NATURE06244
-
Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007;449:804-10 (Pubitemid 47598620)
-
(2007)
Nature
, vol.449
, Issue.7164
, pp. 804-810
-
-
Turnbaugh, P.J.1
Ley, R.E.2
Hamady, M.3
Fraser-Liggett, C.M.4
Knight, R.5
Gordon, J.I.6
-
6
-
-
84880142246
-
Contribution of the intestinal microbiota to human health: From birth to 100 years of age
-
Cheng J, Palva AM, de Vos WM, Satokari R. Contribution of the intestinal microbiota to human health: From birth to 100 years of age. Curr Top Microbiol Immunol 2013;358: 323-46
-
(2013)
Curr Top Microbiol Immunol
, vol.358
, pp. 323-346
-
-
Cheng, J.1
Palva, A.M.2
De Vos, W.M.3
Satokari, R.4
-
7
-
-
82355188259
-
Gut microbiota and probiotics in maternal and infant health
-
Sanz Y. Gut microbiota and probiotics in maternal and infant health. Am J Clin Nutr 2011;94:2000S-5S.
-
(2011)
Am J Clin Nutr
, vol.94
-
-
Sanz, Y.1
-
8
-
-
0031126531
-
The intestinal microflora during the first weeks of life
-
DOI 10.1006/anae.1997.0102
-
Bezirtzoglou E. The intestinal microflora during the first weeks of life. Anaerobe 1997;3:173-7 (Pubitemid 27423147)
-
(1997)
Anaerobe
, vol.3
, Issue.2-3
, pp. 173-177
-
-
Bezirtzoglou, E.1
-
9
-
-
78049502664
-
Longitudinal investigation of the faecal microbiota of healthy full-Term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis
-
Roger LC, McCartney AL. Longitudinal investigation of the faecal microbiota of healthy full-Term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 2010;156:3317-28
-
(2010)
Microbiology
, vol.156
, pp. 3317-3328
-
-
Roger, L.C.1
McCartney, A.L.2
-
10
-
-
78049504118
-
Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life
-
Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 2010;156:3329-41
-
(2010)
Microbiology
, vol.156
, pp. 3329-3341
-
-
Roger, L.C.1
Costabile, A.2
Holland, D.T.3
Hoyles, L.4
McCartney, A.L.5
-
11
-
-
58449119188
-
Establishment of the gut microbiota in Western infants
-
Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009;98:229-38
-
(2009)
Acta Paediatr
, vol.98
, pp. 229-238
-
-
Adlerberth, I.1
Wold, A.E.2
-
12
-
-
79952763661
-
Succession of microbial consortia in the developing infant gut microbiome
-
Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011;108:4578-85
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 4578-4585
-
-
Koenig, J.E.1
Spor, A.2
Scalfone, N.3
Fricker, A.D.4
Stombaugh, J.5
Knight, R.6
-
13
-
-
34547129847
-
Development of the human infant intestinal microbiota
-
Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177
-
(2007)
PLoS Biol
, vol.5
-
-
Palmer, C.1
Bik, E.M.2
DiGiulio, D.B.3
Relman, D.A.4
Brown, P.O.5
-
14
-
-
0026451450
-
In vivo and in vitro models of the human colonic flora
-
Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 1992;31:299-331
-
(1992)
Crit Rev Food Sci Nutr
, vol.31
, pp. 299-331
-
-
Rumney, C.J.1
Rowland, I.R.2
-
16
-
-
20544444045
-
Microbiology: Diversity of the human intestinal microbial flora
-
DOI 10.1126/science.1110591
-
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8 (Pubitemid 40807514)
-
(2005)
Science
, vol.308
, Issue.5728
, pp. 1635-1638
-
-
Eckburg, P.B.1
Bik, E.M.2
Bernstein, C.N.3
Purdom, E.4
Dethlefsen, L.5
Sargent, M.6
Gill, S.R.7
Nelson, K.E.8
Relman, D.A.9
-
17
-
-
34547683600
-
Diversity of the human gastrointestinal tract microbiota revisited
-
DOI 10.1111/j.1462-2920.2007.01369.x
-
Rajilic-Stojanovic M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007;9:2125-36 (Pubitemid 47222128)
-
(2007)
Environmental Microbiology
, vol.9
, Issue.9
, pp. 2125-2136
-
-
Rajilic-Stojanovic, M.1
Smidt, H.2
De Vos, W.M.3
-
19
-
-
42349093774
-
Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques
-
DOI 10.1038/nrmicro1888, PII NRMICRO1888
-
Amann R, Fuchs BM. Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat Rev Microbiol 2008;6:339-48 (Pubitemid 351552655)
-
(2008)
Nature Reviews Microbiology
, vol.6
, Issue.5
, pp. 339-348
-
-
Amann, R.1
Fuchs, B.M.2
-
20
-
-
9644268216
-
Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR
-
DOI 10.1111/j.1365-2672.2004.02409.x
-
Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-Targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-Time PCR. J Appl Microbiol 2004;97:1166-77 (Pubitemid 39573940)
-
(2004)
Journal of Applied Microbiology
, vol.97
, Issue.6
, pp. 1166-1177
-
-
Rinttila, T.1
Kassinen, A.2
Malinen, E.3
Krogius, L.4
Palva, A.5
-
21
-
-
23744446233
-
Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis
-
DOI 10.1128/AEM.71.8.4679-4689.2005
-
Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-Activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 2005; 71:4679-89 (Pubitemid 41129525)
-
(2005)
Applied and Environmental Microbiology
, vol.71
, Issue.8
, pp. 4679-4689
-
-
Ben-Amor, K.1
Heilig, H.2
Smidt, H.3
Vaughan, E.E.4
Abee, T.5
De Vos, W.M.6
-
22
-
-
33947199799
-
Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing
-
DOI 10.1111/j.1574-6941.2007.00281.x
-
Egert M, de Graaf AA, Maathuis A, de WP, Plugge CM, Smidt H, et al. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol 2007; 60:126-35 (Pubitemid 46426584)
-
(2007)
FEMS Microbiology Ecology
, vol.60
, Issue.1
, pp. 126-135
-
-
Egert, M.1
De Graaf, A.A.2
Maathuis, A.3
De Waard, P.4
Plugge, C.M.5
Smidt, H.6
Deutz, N.E.P.7
Dijkema, C.8
De Vos, W.M.9
Venema, K.10
-
23
-
-
79953204638
-
Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples
-
van den Bogert B, de Vos WM, Zoetendal EG, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 2011;77:2071-80
-
(2011)
Appl Environ Microbiol
, vol.77
, pp. 2071-2080
-
-
Van Den Bogert, B.1
De Vos, W.M.2
Zoetendal, E.G.3
Kleerebezem, M.4
-
24
-
-
54349126970
-
High-Throughput diversity and functionality analysis of the gastrointestinal tract microbiota
-
Zoetendal EG, Rajilic-Stojanovic M, De Vos WM. High-Throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008;57:1605-15
-
(2008)
Gut
, vol.57
, pp. 1605-1615
-
-
Zoetendal, E.G.1
Rajilic-Stojanovic, M.2
De Vos, W.M.3
-
25
-
-
77953050946
-
A catalog of reference genomes from the human microbiome
-
Nelson KE, Weinstock GM, Highlander SK, Worley KC, Creasy HH, Wortman JR, et al. A catalog of reference genomes from the human microbiome. Science;2010;328: 994-9
-
(2010)
Science
, vol.328
, pp. 994-999
-
-
Nelson, K.E.1
Weinstock, G.M.2
Highlander, S.K.3
Worley, K.C.4
Creasy, H.H.5
Wortman, J.R.6
-
26
-
-
70449713952
-
The nih human microbiome project
-
Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, et al. The NIH Human Microbiome Project. Genome Res 2009;19:2317-23
-
(2009)
Genome Res
, vol.19
, pp. 2317-2323
-
-
Peterson, J.1
Garges, S.2
Giovanni, M.3
McInnes, P.4
Wang, L.5
Schloss, J.A.6
-
27
-
-
77950251400
-
A human gut microbial gene catalogue established by metagenomic sequencing
-
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464: 59-65
-
(2010)
Nature
, vol.464
, pp. 59-65
-
-
Qin, J.1
Li, R.2
Raes, J.3
Arumugam, M.4
Burgdorf, K.S.5
Manichanh, C.6
-
28
-
-
70349233883
-
Towards the human intestinal microbiota phylogenetic core
-
Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009;11:2574-84
-
(2009)
Environ Microbiol
, vol.11
, pp. 2574-2584
-
-
Tap, J.1
Mondot, S.2
Levenez, F.3
Pelletier, E.4
Caron, C.5
Furet, J.P.6
-
29
-
-
33845901507
-
Microbial ecology: Human gut microbes associated with obesity
-
DOI 10.1038/4441022a, PII 4441022A
-
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature 2006;444:1022-3 (Pubitemid 46018512)
-
(2006)
Nature
, vol.444
, Issue.7122
, pp. 1022-1023
-
-
Ley, R.E.1
Turnbaugh, P.J.2
Klein, S.3
Gordon, J.I.4
-
30
-
-
67651151152
-
The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age
-
Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009;9:123
-
(2009)
BMC Microbiol
, vol.9
, pp. 123
-
-
Mariat, D.1
Firmesse, O.2
Levenez, F.3
Guimaraes, V.4
Sokol, H.5
Dore, J.6
-
31
-
-
34547507259
-
Microbial communities in the human small intestine: Coupling diversity to metagenomics
-
DOI 10.2217/17460913.2.3.285
-
Booijink CC, Zoetendal EG, Kleerebezem M, de Vos WM. Microbial communities in the human small intestine: Coupling diversity to metagenomics. Future Microbiol 2007;2: 285-95 (Pubitemid 47180925)
-
(2007)
Future Microbiology
, vol.2
, Issue.3
, pp. 285-295
-
-
Booijink, C.C.G.M.1
Zoetendal, E.G.2
Kleerebezem, M.3
De Vos, W.M.4
-
32
-
-
80054957238
-
Microflora modulation of motility
-
Quigley EM. Microflora modulation of motility. J Neurogastroenterol Motil 2011;17:140-7
-
(2011)
J Neurogastroenterol Motil
, vol.17
, pp. 140-147
-
-
Quigley, E.M.1
-
33
-
-
0037425743
-
Gut flora in health and disease
-
DOI 10.1016/S0140-6736(03)12489-0
-
Guarner F, Malagelada Jr. Gut flora in health and disease. Lancet 2003;361:512-19 (Pubitemid 36173720)
-
(2003)
Lancet
, vol.361
, Issue.9356
, pp. 512-519
-
-
Guarner, F.1
Malagelada, J.-R.2
-
34
-
-
56849106496
-
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing
-
Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280
-
(2008)
PLoS Biol
, vol.6
-
-
Dethlefsen, L.1
Huse, S.2
Sogin, M.L.3
Relman, D.A.4
-
35
-
-
85027927719
-
Enterotypes of the human gut microbiome
-
Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-80
-
(2011)
Nature
, vol.473
, pp. 174-180
-
-
Arumugam, M.1
Raes, J.2
Pelletier, E.3
Le, P.D.4
Yamada, T.5
Mende, D.R.6
-
36
-
-
69849114201
-
The degree of microbiome complexity influences the epithelial response to infection
-
Mans JJ, von LK, Dorsey C, Willis S, Wallet SM, Baker HV, et al. The degree of microbiome complexity influences the epithelial response to infection. BMC Genomics 2009;10:380
-
(2009)
BMC Genomics
, vol.10
, pp. 380
-
-
Mans, J.J.1
Von, L.K.2
Dorsey, C.3
Willis, S.4
Wallet, S.M.5
Baker, H.V.6
-
37
-
-
20444493331
-
The interaction between bacteria and bile
-
DOI 10.1016/j.femsre.2004.09.003, PII S0168644504000646
-
Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005;29:625-51 (Pubitemid 41139175)
-
(2005)
FEMS Microbiology Reviews
, vol.29
, Issue.4
, pp. 625-651
-
-
Begley, M.1
Gahan, C.G.M.2
Hill, C.3
-
38
-
-
33244467651
-
Bile salt biotransformations by human intestinal bacteria
-
DOI 10.1194/jlr.R500013-JLR200
-
Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241-59 (Pubitemid 43276911)
-
(2006)
Journal of Lipid Research
, vol.47
, Issue.2
, pp. 241-259
-
-
Ridlon, J.M.1
Kang, D.-J.2
Hylemon, P.B.3
-
39
-
-
58249110568
-
Role of bile acids and bile acid receptors in metabolic regulation
-
Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147-91
-
(2009)
Physiol Rev
, vol.89
, pp. 147-191
-
-
Lefebvre, P.1
Cariou, B.2
Lien, F.3
Kuipers, F.4
Staels, B.5
-
40
-
-
33748209543
-
Colonic health: Fermentation and short chain fatty acids
-
DOI 10.1097/00004836-200603000-00015, PII 0000483620060300000015
-
Wong JM, de SR, Kendall CW, Emam A, Jenkins DJ. Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235-43 (Pubitemid 44309560)
-
(2006)
Journal of Clinical Gastroenterology
, vol.40
, Issue.3
, pp. 235-243
-
-
Wong, J.M.W.1
De Souza, R.2
Kendall, C.W.C.3
Emam, A.4
Jenkins, D.J.A.5
-
41
-
-
41449101412
-
Short chain fatty acids and colonic health
-
Hijova E, Chmelarova A. Short chain fatty acids and colonic health. Bratisl Lek Listy 2007;108:354-8
-
(2007)
Bratisl Lek Listy
, vol.108
, pp. 354-358
-
-
Hijova, E.1
Chmelarova, A.2
-
43
-
-
84862017188
-
Gut microbiota and nonalcoholic fatty liver disease
-
Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 2012;11:440-9
-
(2012)
Ann Hepatol
, vol.11
, pp. 440-449
-
-
Machado, M.V.1
Cortez-Pinto, H.2
-
44
-
-
79957902145
-
Gut microbiome, obesity, and metabolic dysfunction
-
Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011;121:2126-32
-
(2011)
J Clin Invest
, vol.121
, pp. 2126-2132
-
-
Tilg, H.1
Kaser, A.2
-
45
-
-
78650465542
-
Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk
-
Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010;31:817-44
-
(2010)
Endocr Rev
, vol.31
, pp. 817-844
-
-
Manco, M.1
Putignani, L.2
Bottazzo, G.F.3
-
46
-
-
84857729398
-
Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
-
Serino M, Luche E, Gres S, Baylac A, Berge M, Cenac C, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012;61: 543-53
-
(2012)
Gut
, vol.61
, pp. 543-553
-
-
Serino, M.1
Luche, E.2
Gres, S.3
Baylac, A.4
Berge, M.5
Cenac, C.6
-
47
-
-
84858590812
-
Gut microbiota: Next frontier in understanding human health and development of biotherapeutics
-
Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: Next frontier in understanding human health and development of biotherapeutics. Biologics 2011;5:71-86
-
(2011)
Biologics
, vol.5
, pp. 71-86
-
-
Prakash, S.1
Rodes, L.2
Coussa-Charley, M.3
Tomaro-Duchesneau, C.4
-
48
-
-
77954051526
-
Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses
-
Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010;328:1705-9
-
(2010)
Science
, vol.328
, pp. 1705-1709
-
-
Hapfelmeier, S.1
Lawson, M.A.2
Slack, E.3
Kirundi, J.K.4
Stoel, M.5
Heikenwalder, M.6
-
49
-
-
85027947787
-
Induction of colonic regulatory T cells by indigenous clostridium species
-
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 2011;331:337-41
-
(2011)
Science
, vol.331
, pp. 337-341
-
-
Atarashi, K.1
Tanoue, T.2
Shima, T.3
Imaoka, A.4
Kuwahara, T.5
Momose, Y.6
-
50
-
-
70350343544
-
Induction of intestinal Th17 cells by segmented filamentous bacteria
-
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485-98
-
(2009)
Cell
, vol.139
, pp. 485-498
-
-
Ivanov, I.I.1
Atarashi, K.2
Manel, N.3
Brodie, E.L.4
Shima, T.5
Karaoz, U.6
-
51
-
-
0036212170
-
Butyrate inhibits NF-κB activation in lamina propria macrophages of patients with ulcerative colitis
-
DOI 10.1080/003655202317316105
-
Luhrs H, Gerke T, Muller JG, Melcher R, Schauber J, Boxberge F, et al. Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002;37:458-66 (Pubitemid 34274331)
-
(2002)
Scandinavian Journal of Gastroenterology
, vol.37
, Issue.4
, pp. 458-466
-
-
Luhrs, H.1
Gerke, T.2
Muller, J.G.3
Melcher, R.4
Schauber, J.5
Boxberger, F.6
Scheppach, W.7
Menzel, T.8
-
52
-
-
70350666634
-
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
-
Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009;461:1282-6
-
(2009)
Nature
, vol.461
, pp. 1282-1286
-
-
Maslowski, K.M.1
Vieira, A.T.2
Ng, A.3
Kranich, J.4
Sierro, F.5
Yu, D.6
-
53
-
-
23044509165
-
Modulation of gut mucosal biofilms
-
DOI 10.1079/BJN20041346
-
Kleessen B, Blaut M. Modulation of gut mucosal biofilms. Br J Nutr 2005;93:S35-40 (Pubitemid 43073405)
-
(2005)
British Journal of Nutrition
, vol.93
, Issue.SUPPL.
-
-
Kleessen, B.1
Blaut, M.2
-
54
-
-
37149022209
-
Review article: The role of butyrate on colonic function
-
DOI 10.1111/j.1365-2036.2007.03562.x
-
Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 2008;27:104-19 (Pubitemid 350256609)
-
(2008)
Alimentary Pharmacology and Therapeutics
, vol.27
, Issue.2
, pp. 104-119
-
-
Hamer, H.M.1
Jonkers, D.2
Venema, K.3
Vanhoutvin, S.4
Troost, F.J.5
Brummer, R.-J.6
-
55
-
-
0031812434
-
Presidential address: Gastrointestinal illness and the biopsychosocial model
-
Drossman DA. Presidential address: Gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998;60: 258-67 (Pubitemid 28279969)
-
(1998)
Psychosomatic Medicine
, vol.60
, Issue.3
, pp. 258-267
-
-
Drossman, D.A.1
-
56
-
-
84872296174
-
Voices from within: Gut microbes and the CNS
-
Forsythe P, Kunze WA. Voices from within: Gut microbes and the CNS. Cell Mol Life Sci 2013;70:55-69
-
(2013)
Cell Mol Life Sci
, vol.70
, pp. 55-69
-
-
Forsythe, P.1
Kunze, W.A.2
-
57
-
-
67650333217
-
Principles and clinical implications of the brain-gut-enteric microbiota axis
-
Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009;6:306-14
-
(2009)
Nat Rev Gastroenterol Hepatol
, vol.6
, pp. 306-314
-
-
Rhee, S.H.1
Pothoulakis, C.2
Mayer, E.A.3
-
58
-
-
79551694651
-
The microbiome-gut-brain axis: From bowel to behavior
-
Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil 2011;23: 187-92
-
(2011)
Neurogastroenterol Motil
, vol.23
, pp. 187-192
-
-
Cryan, J.F.1
O'Mahony, S.M.2
-
59
-
-
4043161248
-
Postnatal microbial colonization programs the hypothalamic-pituitary- adrenal system for stress response in mice
-
DOI 10.1113/jphysiol.2004.063388
-
Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-Adrenal system for stress response in mice. J Physiol 2004;558:263-75 (Pubitemid 39077406)
-
(2004)
Journal of Physiology
, vol.558
, Issue.1
, pp. 263-275
-
-
Sudo, N.1
Chida, Y.2
Aiba, Y.3
Sonoda, J.4
Oyama, N.5
Yu, X.-N.6
Kubo, C.7
Koga, Y.8
-
60
-
-
79551713705
-
Reduced anxiety-like behavior and central neurochemical change in germ-free mice
-
e119
-
Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011;23:255-64, e119
-
(2011)
Neurogastroenterol Motil
, vol.23
, pp. 255-264
-
-
Neufeld, K.M.1
Kang, N.2
Bienenstock, J.3
Foster, J.A.4
-
61
-
-
79952601424
-
Normal gut microbiota modulates brain development and behavior
-
Diaz HR, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011; 108:3047-52
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 3047-3052
-
-
Diaz, H.R.1
Wang, S.2
Anuar, F.3
Qian, Y.4
Bjorkholm, B.5
Samuelsson, A.6
-
62
-
-
79851494165
-
Bacterial infection causes stress-induced memory dysfunction in mice
-
Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011;60:307-17
-
(2011)
Gut
, vol.60
, pp. 307-317
-
-
Gareau, M.G.1
Wine, E.2
Rodrigues, D.M.3
Cho, J.H.4
Whary, M.T.5
Philpott, D.J.6
-
63
-
-
81855194317
-
The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication
-
Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011;23:1132-9
-
(2011)
Neurogastroenterol Motil
, vol.23
, pp. 1132-1139
-
-
Bercik, P.1
Park, A.J.2
Sinclair, D.3
Khoshdel, A.4
Lu, J.5
Huang, X.6
-
64
-
-
78149501207
-
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice
-
Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010;139:2102-12
-
(2010)
Gastroenterology
, vol.139
, pp. 2102-2112
-
-
Bercik, P.1
Verdu, E.F.2
Foster, J.A.3
Macri, J.4
Potter, M.5
Huang, X.6
-
65
-
-
80052965474
-
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
-
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108:16050-5
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 16050-16055
-
-
Bravo, J.A.1
Forsythe, P.2
Chew, M.V.3
Escaravage, E.4
Savignac, H.M.5
Dinan, T.G.6
-
66
-
-
32044459306
-
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker?
-
DOI 10.1053/j.gastro.2005.11.033, PII S0016508505023942
-
Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: Plasma cytokines as a potential biomarker? Gastroenterology 2006;130:304-11 (Pubitemid 43202030)
-
(2006)
Gastroenterology
, vol.130
, Issue.2
, pp. 304-311
-
-
Dinan, T.G.1
Quigley, E.M.M.2
Ahmed, S.M.M.3
Scully, P.4
O'Brien, S.5
O'Mahony, L.6
O'Mahony, S.7
Shanahan, F.8
Keeling, P.W.N.9
-
68
-
-
20444374493
-
Activation in vagal afferents and central autonomic pathways: Early responses to intestinal infection with Campylobacter jejuni
-
DOI 10.1016/j.bbi.2004.09.002, PII S0889159104001278
-
Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M. Activation in vagal afferents and central autonomic pathways: Early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005;19:334-44 (Pubitemid 40797990)
-
(2005)
Brain, Behavior, and Immunity
, vol.19
, Issue.4
, pp. 334-344
-
-
Goehler, L.E.1
Gaykema, R.P.A.2
Opitz, N.3
Reddaway, R.4
Badr, N.5
Lyte, M.6
-
69
-
-
33646201684
-
Functional bowel disorders
-
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91
-
(2006)
Gastroenterology
, vol.130
, pp. 1480-1491
-
-
Longstreth, G.F.1
Thompson, W.G.2
Chey, W.D.3
Houghton, L.A.4
Mearin, F.5
Spiller, R.C.6
-
70
-
-
0036893761
-
AGA technical review on irritable bowel syndrome
-
DOI 10.1053/gast.2002.37095
-
Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31 (Pubitemid 35408332)
-
(2002)
Gastroenterology
, vol.123
, Issue.6
, pp. 2108-2131
-
-
Drossman, D.A.1
Camilleri, M.2
Mayer, E.A.3
Whitehead, W.E.4
-
71
-
-
0034530999
-
Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBD)
-
DOI 10.1023/A:1010770302403
-
Simren M, Castedal M, Svedlund J, Abrahamsson H, Bjornsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci 2000;45:2151-61 (Pubitemid 32060385)
-
(2000)
Digestive Diseases and Sciences
, vol.45
, Issue.11
, pp. 2151-2161
-
-
Simren, M.1
Castedal, M.2
Svedlund, J.3
Abrahamsson, H.4
Bjornsson, E.5
-
72
-
-
0022352734
-
The irritable bowel syndrome: A proxysmal disorder
-
Kumar D, Wingate DL. The irritable bowel syndrome: A paroxysmal motor disorder. Lancet 1985;2:973-7 (Pubitemid 16215443)
-
(1985)
Lancet
, vol.2
, Issue.8462
, pp. 973-977
-
-
Kumar, D.1
Wingate, D.L.2
-
73
-
-
0029950915
-
Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome
-
Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A, Kaess H. Ambulatory 24-hour jejunal motility in diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 1996;31:581-9 (Pubitemid 26196139)
-
(1996)
Scandinavian Journal of Gastroenterology
, vol.31
, Issue.6
, pp. 581-589
-
-
Schmidt, T.1
Hackelsberger, N.2
Widmer, R.3
Meisel, C.4
Pfeiffer, A.5
Kaess, H.6
-
74
-
-
0025271914
-
Tolerance for rectosigmoid distention in irritable bowel syndrome
-
Whitehead WE, Holtkotter B, Enck P, Hoelzl R, Holmes KD, Anthony J, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98:1187-92 (Pubitemid 20143101)
-
(1990)
Gastroenterology
, vol.98
, Issue.5
, pp. 1187-1192
-
-
Whitehead, W.E.1
Holtkotter, B.2
Enck, P.3
Hoelzl, R.4
Holmes, K.D.5
Anthony, J.6
Shabsin, H.S.7
Schuster, M.M.8
-
75
-
-
0036079899
-
Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds
-
Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, et al. Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771-7 (Pubitemid 34651420)
-
(2002)
Gastroenterology
, vol.122
, Issue.7
, pp. 1771-1777
-
-
Bouin, M.1
Plourde, V.2
Boivin, M.3
Riberdy, M.4
Lupien, F.5
Laganiere, M.6
Verrier, P.7
Poitras, P.8
-
76
-
-
33744800331
-
Visceral hypersensitivity following cold water intake in subjects with irritable bowel syndrome
-
DOI 10.1007/s00535-005-1766-x
-
Zuo XL, Li YQ, Shi L, Lv GP, Kuang RG, Lu XF, et al. Visceral hypersensitivity following cold water intake in subjects with irritable bowel syndrome. J Gastroenterol 2006;41: 311-17 (Pubitemid 43834373)
-
(2006)
Journal of Gastroenterology
, vol.41
, Issue.4
, pp. 311-317
-
-
Zuo, X.L.1
Li, Y.Q.2
Shi, L.3
Lv, G.P.4
Kuang, R.G.5
Lu, X.F.6
Li, J.M.7
Desmond, P.V.8
-
77
-
-
33749039592
-
Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome
-
Nozu T, KudairaM, Kitamori S, Uehara A. Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome. J Gastroenterol 2006;41:217-22
-
(2006)
J Gastroenterol
, vol.41
, pp. 217-222
-
-
Nozu, T.1
KudairaM Kitamori, S.2
Uehara, A.3
-
78
-
-
0036083346
-
Activation of the mucosal immune system in irritable bowel syndrome
-
Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-83 (Pubitemid 34651421)
-
(2002)
Gastroenterology
, vol.122
, Issue.7
, pp. 1778-1783
-
-
Chadwick, V.S.1
Chen, W.2
Shu, D.3
Paulus, B.4
Bethwaite, P.5
Tie, A.6
Wilson, I.7
-
79
-
-
33947324517
-
Immune Activation in Patients With Irritable Bowel Syndrome
-
DOI 10.1053/j.gastro.2007.01.046, PII S0016508507001850
-
Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913-20 (Pubitemid 46440872)
-
(2007)
Gastroenterology
, vol.132
, Issue.3
, pp. 913-920
-
-
Liebregts, T.1
Adam, B.2
Bredack, C.3
Roth, A.4
Heinzel, S.5
Lester, S.6
Downie-Doyle, S.7
Smith, E.8
Drew, P.9
Talley, N.J.10
Holtmann, G.11
-
81
-
-
34547477105
-
Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome
-
DOI 10.1111/j.1365-2036.2007.03399.x
-
Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-Analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:535-44 (Pubitemid 47174284)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.26
, Issue.4
, pp. 535-544
-
-
Thabane, M.1
Kottachchi, D.T.2
Marshall, J.K.3
-
82
-
-
27644503956
-
The genetics of irritable bowel syndrome
-
DOI 10.1016/S1542-3565(05)00184-9, PII S1542356505001849
-
Saito YA, Petersen GM, Locke GR 3rd, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:1057-65 (Pubitemid 41565369)
-
(2005)
Clinical Gastroenterology and Hepatology
, vol.3
, Issue.11
, pp. 1057-1065
-
-
Saito, Y.A.1
Petersen, G.M.2
Locke III, G.R.3
Talley, N.J.4
-
83
-
-
79952305589
-
The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome
-
Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140:761-5
-
(2011)
Gastroenterology
, vol.140
, pp. 761-765
-
-
Chang, L.1
-
84
-
-
38649131433
-
Alterations in Mucosal Immunity Identified in the Colon of Patients With Irritable Bowel Syndrome
-
DOI 10.1016/j.cgh.2007.11.012, PII S1542356507011081
-
Aerssens J, Camilleri M, Talloen W, Thielemans L, Gohlmann HW, Van DW, et al. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008;6:194-205 (Pubitemid 351172944)
-
(2008)
Clinical Gastroenterology and Hepatology
, vol.6
, Issue.2
, pp. 194-205
-
-
Aerssens, J.1
Camilleri, M.2
Talloen, W.3
Thielemans, L.4
Gohlmann, H.W.H.5
Van Den Wyngaert, I.6
Thielemans, T.7
De Hoogt, R.8
Andrews, C.N.9
Bharucha, A.E.10
Carlson, P.J.11
Busciglio, I.12
Burton, D.D.13
Smyrk, T.14
Urrutia, R.15
Coulie, B.16
-
85
-
-
12844273701
-
Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - A longitudinal study in IBS and control subjects
-
DOI 10.1016/j.femsim.2004.08.009, PII S0928824404001889
-
Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-A longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005;43:213-22 (Pubitemid 40170291)
-
(2005)
FEMS Immunology and Medical Microbiology
, vol.43
, Issue.2
, pp. 213-222
-
-
Matto, J.1
Maunuksela, L.2
Kajander, K.3
Palva, A.4
Riitta Korpela5
Anna Kassinen6
Saarela, M.7
-
86
-
-
33646259477
-
Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria
-
Maukonen J, Satokari R, Matto J, Soderlund H, Mattila-Sandholm T, Saarela M. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006;55:625-33
-
(2006)
J Med Microbiol
, vol.55
, pp. 625-633
-
-
Maukonen, J.1
Satokari, R.2
Matto, J.3
Soderlund, H.4
Mattila-Sandholm, T.5
Saarela, M.6
-
87
-
-
76849116160
-
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome
-
Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi Jr. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010;55:392-7
-
(2010)
Dig Dis Sci
, vol.55
, pp. 392-397
-
-
Codling, C.1
O'Mahony, L.2
Shanahan, F.3
Quigley, E.M.4
Marchesi, J.R.5
-
88
-
-
13944255868
-
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR
-
DOI 10.1111/j.1572-0241.2005.40312.x
-
Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-Time PCR. Am J Gastroenterol 2005;100:373-82 (Pubitemid 40314522)
-
(2005)
American Journal of Gastroenterology
, vol.100
, Issue.2
, pp. 373-382
-
-
Malinen, E.1
Rinttila, T.2
Kajander, K.3
Matto, J.4
Kassinen, A.5
Krogius, L.6
Saarela, M.7
Korpela, R.8
Palva, A.9
-
89
-
-
74549200558
-
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification
-
Lyra A, Rinttila T, Nikkila J, Krogius-Kurikka L, Kajander K, Malinen E, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009;15: 5936-45
-
(2009)
World J Gastroenterol
, vol.15
, pp. 5936-5945
-
-
Lyra, A.1
Rinttila, T.2
Nikkila, J.3
Krogius-Kurikka, L.4
Kajander, K.5
Malinen, E.6
-
90
-
-
77950670562
-
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome
-
Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:512-15
-
(2010)
Neurogastroenterol Motil
, vol.22
, pp. 512-515
-
-
Tana, C.1
Umesaki, Y.2
Imaoka, A.3
Handa, T.4
Kanazawa, M.5
Fukudo, S.6
-
91
-
-
79957601426
-
Microbial community and metabolomic comparison of irritable bowel syndrome faeces
-
Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 2011;60:817-27
-
(2011)
J Med Microbiol
, vol.60
, pp. 817-827
-
-
Ponnusamy, K.1
Choi, J.N.2
Kim, J.3
Lee, S.Y.4
Lee, C.H.5
-
92
-
-
0032505571
-
Abnormal colonic fermentation in irritable bowel syndrome
-
DOI 10.1016/S0140-6736(98)02146-1
-
King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352:1187-9 (Pubitemid 28458534)
-
(1998)
Lancet
, vol.352
, Issue.9135
, pp. 1187-1189
-
-
King, T.S.1
Elia, M.2
Hunter, J.O.3
-
93
-
-
34447104397
-
The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects
-
DOI 10.1053/j.gastro.2007.04.005, PII S0016508507007342
-
Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007;133:24-33 (Pubitemid 47031125)
-
(2007)
Gastroenterology
, vol.133
, Issue.1
, pp. 24-33
-
-
Kassinen, A.1
Krogius-Kurikka, L.2
Makivuokko, H.3
Rinttila, T.4
Paulin, L.5
Corander, J.6
Malinen, E.7
Apajalahti, J.8
Palva, A.9
-
94
-
-
74549185684
-
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
-
Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009;9: 95
-
(2009)
BMC Gastroenterol
, vol.9
, pp. 95
-
-
Krogius-Kurikka, L.1
Lyra, A.2
Malinen, E.3
Aarnikunnas, J.4
Tuimala, J.5
Paulin, L.6
-
95
-
-
0035059367
-
Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain
-
DOI 10.1016/S0304-3959(00)00467-X, PII S030439590000467X
-
Michl T, Jocic M, Heinemann A, Schuligoi R, Holzer P. Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 2001;92:19-27 (Pubitemid 32367933)
-
(2001)
Pain
, vol.92
, Issue.1-2
, pp. 19-27
-
-
Michl, T.1
Jocic, M.2
Heinemann, A.3
Schuligoi, R.4
Holzer, P.5
-
96
-
-
22144476548
-
Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
-
DOI 10.1128/JCM.43.7.3380-3389.2005
-
Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005;43:3380-9 (Pubitemid 40981351)
-
(2005)
Journal of Clinical Microbiology
, vol.43
, Issue.7
, pp. 3380-3389
-
-
Swidsinski, A.1
Weber, J.2
Loening-Baucke, V.3
Hale, L.P.4
Lochs, H.5
-
97
-
-
80051785670
-
Luminal and mucosal-Associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
-
Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-Associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathogens 2010;2:19
-
(2010)
Gut Pathogens
, vol.2
, pp. 19
-
-
Carroll, I.M.1
Chang, Y.H.2
Park, J.3
Sartor, R.B.4
Ringel, Y.5
-
98
-
-
67651252736
-
Lower Bifidobacteria counts in both duodenal mucosa-Associated and fecal microbiota in irritable bowel syndrome patients
-
Kerckhoffs AP, Samsom M, van der Rest ME, de VJ, Knol J, Ben-Amor K, et al. Lower Bifidobacteria counts in both duodenal mucosa-Associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009;15: 2887-92
-
(2009)
World J Gastroenterol
, vol.15
, pp. 2887-2892
-
-
Kerckhoffs, A.P.1
Samsom, M.2
Van Der Rest, M.E.3
De, V.J.4
Knol, J.5
Ben-Amor, K.6
-
99
-
-
84870866715
-
An Update on post-infectious irritable bowel syndrome: Role of genetics, immune activation, serotonin and altered microbiome
-
Spiller R, Lam C. An Update on post-infectious irritable bowel syndrome: Role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012;18:258-68
-
(2012)
J Neurogastroenterol Motil
, vol.18
, pp. 258-268
-
-
Spiller, R.1
Lam, C.2
-
100
-
-
52049083187
-
Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients
-
Schoepfer AM, Schaffer T, Seibold-Schmid B, Muller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008;20:1110-18
-
(2008)
Neurogastroenterol Motil
, vol.20
, pp. 1110-1118
-
-
Schoepfer, A.M.1
Schaffer, T.2
Seibold-Schmid, B.3
Muller, S.4
Seibold, F.5
-
101
-
-
78049496695
-
Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives
-
Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 2010;156:3205-15
-
(2010)
Microbiology
, vol.156
, pp. 3205-3215
-
-
Salonen, A.1
De Vos, W.M.2
Palva, A.3
-
102
-
-
3242728473
-
-
FAO/WHO Basel, Switzerland: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria
-
FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Basel, Switzerland: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria; 2001
-
(2001)
Health And Nutritional Properties Of Probiotics In Food Including Powder Milk With Live Lactic Acid Bacteria
-
-
-
103
-
-
40749160476
-
Probiotics in irritable bowel syndrome an immunomodulatory strategy?
-
Quigley EM. Probiotics in irritable bowel syndrome: An immunomodulatory strategy? J Am Coll Nutr 2007; 26:684S-90S.
-
(2007)
J Am Coll Nutr
, vol.26
-
-
Quigley, E.M.1
-
104
-
-
65449125343
-
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gastroenterology enters the metagenomics era
-
Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gastroenterology enters the metagenomics era. Gastroenterology 2009;136: 2015-31
-
(2009)
Gastroenterology
, vol.136
, pp. 2015-2031
-
-
Preidis, G.A.1
Versalovic, J.2
-
105
-
-
33846926968
-
Probiotics and irritable bowel syndrome: A rationale for their use and an assessment of the evidence to date
-
DOI 10.1111/j.1365-2982.2006.00879.x
-
Quigley EM, Flourie B. Probiotics and irritable bowel syndrome: A rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007;19: 166-72 (Pubitemid 46239427)
-
(2007)
Neurogastroenterology and Motility
, vol.19
, Issue.3
, pp. 166-172
-
-
Quigley, E.M.M.1
Flourie, B.2
-
106
-
-
77954832198
-
Probiotics-host communication: Modulation of signaling pathways in the intestine
-
Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes 2010;1:148-63
-
(2010)
Gut Microbes
, vol.1
, pp. 148-163
-
-
Thomas, C.M.1
Versalovic, J.2
-
107
-
-
0033921870
-
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
-
O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000;32: 294-301 (Pubitemid 30445067)
-
(2000)
Digestive and Liver Disease
, vol.32
, Issue.4
, pp. 294-301
-
-
O'Sullivan, M.A.1
O'Morain, C.A.2
-
108
-
-
0034059773
-
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
-
DOI 10.1016/S0002-9270(00)00807-8, PII S0002927000008078
-
Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231-8 (Pubitemid 30263518)
-
(2000)
American Journal of Gastroenterology
, vol.95
, Issue.5
, pp. 1231-1238
-
-
Nobaek, S.1
Johansson, M.-L.2
Molin, G.3
Ahrne, S.4
Jeppsson, B.5
-
109
-
-
33745569311
-
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
-
DOI 10.1111/j.1572-0241.2006.00734.x
-
Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101:1581-90 (Pubitemid 43980633)
-
(2006)
American Journal of Gastroenterology
, vol.101
, Issue.7
, pp. 1581-1590
-
-
Whorwell, P.J.1
Altringer, L.2
Morel, J.3
Bond, Y.4
Charbonneau, D.5
O'Mahony, L.6
Kiely, B.7
Shanahan, F.8
Quigley, E.M.M.9
-
110
-
-
65449172901
-
The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review
-
Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review. Am J Gastroenterol 2009; 104:1033-49
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1033-1049
-
-
Brenner, D.M.1
Moeller, M.J.2
Chey, W.D.3
Schoenfeld, P.S.4
-
111
-
-
15744374565
-
Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
-
DOI 10.1053/j.gastro.2004.11.050
-
O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51 (Pubitemid 40585355)
-
(2005)
Gastroenterology
, vol.128
, Issue.3
, pp. 541-551
-
-
O'Mahony, L.1
Mccarthy, J.2
Kelly, P.3
Hurley, G.4
Luo, F.5
Chen, K.6
O'Sullivan, G.C.7
Kiely, B.8
Collins, J.K.9
Shanahan, F.10
Quigley, E.M.M.11
-
112
-
-
22044455039
-
Do probiotics reduce adult lactose intolerance? A systematic review
-
Levri KM, Ketvertis K, Deramo M, Merenstein JH, D'Amico F. Do probiotics reduce adult lactose intolerance? A systematic review. J Fam Pract 2005;54:613-20 (Pubitemid 40967734)
-
(2005)
Journal of Family Practice
, vol.54
, Issue.7
, pp. 613-620
-
-
Levri, K.M.1
Ketvertis, K.2
Deramo, M.3
Merenstein, J.H.4
D'Amico, F.5
-
113
-
-
77749318556
-
The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review
-
Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010;59:325-32
-
(2010)
Gut
, vol.59
, pp. 325-332
-
-
Moayyedi, P.1
Ford, A.C.2
Talley, N.J.3
Cremonini, F.4
Foxx-Orenstein, A.E.5
Brandt, L.J.6
-
114
-
-
58149105515
-
Probiotics and irritable bowel syndrome: Rationale, mechanisms, and efficacy
-
Camilleri M. Probiotics and irritable bowel syndrome: Rationale, mechanisms, and efficacy. J Clin Gastroenterol 2008;42:S123-5
-
(2008)
J Clin Gastroenterol
, vol.42
-
-
Camilleri, M.1
-
115
-
-
49649088887
-
Meta-Analysis of probiotics for the treatment of irritable bowel syndrome
-
McFarland LV, Dublin S. Meta-Analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008;14:2650-61
-
(2008)
World J Gastroenterol
, vol.14
, pp. 2650-2661
-
-
McFarland, L.V.1
Dublin, S.2
-
116
-
-
68649111410
-
Alterations in the intestinal microbiota and functional bowel symptoms
-
vii
-
Ringel Y, Carroll IM. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am 2009;19:141-50, vii
-
(2009)
Gastrointest Endosc Clin N Am
, vol.19
, pp. 141-150
-
-
Ringel, Y.1
Carroll, I.M.2
-
117
-
-
4844226594
-
Probiotics in the treatment of irritable bowel syndrome
-
Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004;38:S104-6
-
(2004)
J Clin Gastroenterol
, vol.38
-
-
Saggioro, A.1
-
118
-
-
0037392231
-
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome
-
DOI 10.1046/j.1365-2036.2003.01543.x
-
Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895-904 (Pubitemid 36459602)
-
(2003)
Alimentary Pharmacology and Therapeutics
, vol.17
, Issue.7
, pp. 895-904
-
-
Kim, H.J.1
Camilleri, M.2
McKinzie, S.3
Lempke, M.B.4
Burton, D.D.5
Thomforde, G.M.6
Zinsmeister, A.R.7
-
119
-
-
43149106687
-
A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome
-
DOI 10.1016/j.gcb.2007.06.001, PII S0399832008000456
-
Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008;32:147-52 (Pubitemid 351637577)
-
(2008)
Gastroenterologie Clinique et Biologique
, vol.32
, Issue.2
, pp. 147-152
-
-
Drouault-Holowacz, S.1
Bieuvelet, S.2
Burckel, A.3
Cazaubiel, M.4
Dray, X.5
Marteau, P.6
-
120
-
-
79954738618
-
Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-A double-blind, placebo-controlled study
-
Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-A double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011;33:1123-32
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 1123-1132
-
-
Guglielmetti, S.1
Mora, D.2
Gschwender, M.3
Popp, K.4
-
121
-
-
35448956122
-
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues
-
DOI 10.1159/000103893
-
Cuomo R, Savarese MF, Gargano R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues. Dig Dis 2007;25:241-4 (Pubitemid 350194176)
-
(2007)
Digestive Diseases
, vol.25
, Issue.3
, pp. 241-244
-
-
Cuomo, R.1
Savarese, M.F.2
Gargano, R.3
-
122
-
-
53149099016
-
Prebiotics as gut microflora management tools
-
Gibson GR. Prebiotics as gut microflora management tools. J Clin Gastroenterol 2008;42:S75-9
-
(2008)
J Clin Gastroenterol
, vol.42
-
-
Gibson, G.R.1
-
123
-
-
70350662669
-
Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal
-
Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90:1236-43
-
(2009)
Am J Clin Nutr
, vol.90
, pp. 1236-1243
-
-
Cani, P.D.1
Lecourt, E.2
Dewulf, E.M.3
Sohet, F.M.4
Pachikian, B.D.5
Naslain, D.6
-
124
-
-
33947136322
-
Prebiotics: The concept revisited
-
Roberfroid M. Prebiotics: The concept revisited. J Nutr 2007;137:830S-7S.
-
(2007)
J Nutr
, vol.137
-
-
Roberfroid, M.1
-
126
-
-
0033661618
-
Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome
-
Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 2000;72:1570-5
-
(2000)
Am J Clin Nutr
, vol.72
, pp. 1570-1575
-
-
Olesen, M.1
Gudmand-Hoyer, E.2
-
127
-
-
0033006874
-
Controlled trial of oligofructose in the management of irritable bowel syndrome
-
Hunter JO, Tuffnell Q, Lee AJ. Controlled trial of oligofructose in the management of irritable bowel syndrome. J Nutr 1999;129:1451S-3S. (Pubitemid 29302778)
-
(1999)
Journal of Nutrition
, vol.129
, Issue.7 SUPPL.
-
-
Hunter, J.O.1
Tuffnell, Q.2
Lee, A.J.3
-
128
-
-
59149093199
-
Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
-
Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009;29:508-18
-
(2009)
Aliment Pharmacol Ther
, vol.29
, pp. 508-518
-
-
Silk, D.B.1
Davis, A.2
Vulevic, J.3
Tzortzis, G.4
Gibson, G.R.5
-
129
-
-
58149137305
-
Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: A multicenter, randomized study
-
Andriulli A, Neri M, Loguercio C, Terreni N, Merla A, Cardarella MP, et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: A multicenter, randomized study. J Clin Gastroenterol 2008;42:S218-23
-
(2008)
J Clin Gastroenterol
, vol.42
-
-
Andriulli, A.1
Neri, M.2
Loguercio, C.3
Terreni, N.4
Merla, A.5
Cardarella, M.P.6
-
130
-
-
0030724859
-
Metronidazole relieves symptoms in irritable bowel syndrome: The confusion with so-called 'chronic amebiasis'
-
Nayak AK, Karnad DR, Abraham P, Mistry FP. Metronidazole relieves symptoms in irritable bowel syndrome: The confusion with so-called 'chronic amebiasis'. Indian J Gastroenterol 1997;16:137-9 (Pubitemid 27467189)
-
(1997)
Indian Journal of Gastroenterology
, vol.16
, Issue.4
, pp. 137-139
-
-
Nayak, A.K.1
Karnad, D.R.2
Abraham, P.3
Mistry, F.P.4
-
131
-
-
33644912601
-
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
-
DOI 10.1111/j.1572-0241.2006.00458.x
-
Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326-33 (Pubitemid 43381675)
-
(2006)
American Journal of Gastroenterology
, vol.101
, Issue.2
, pp. 326-333
-
-
Sharara, A.I.1
Aoun, E.2
Abdul-Baki, H.3
Mounzer, R.4
Sidani, S.5
Elhajj, I.6
-
132
-
-
0037280318
-
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: A double-blind, randomized, placebo-controlled study
-
DOI 10.1016/S0002-9270(02)05902-6
-
Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98: 412-19 (Pubitemid 36232393)
-
(2003)
American Journal of Gastroenterology
, vol.98
, Issue.2
, pp. 412-419
-
-
Pimentel, M.1
Chow, E.J.2
Lin, H.C.3
-
133
-
-
33750721328
-
The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial
-
Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial. Ann Intern Med 2006;145:557-63 (Pubitemid 46780934)
-
(2006)
Annals of Internal Medicine
, vol.145
, Issue.8
, pp. 557-563
-
-
Pimentel, M.1
Park, S.2
Mirocha, J.3
Kane, S.V.4
Kong, Y.5
-
134
-
-
78650864077
-
Rifaximin therapy for patients with irritable bowel syndrome without constipation
-
Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364:22-32
-
(2011)
N Engl J Med
, vol.364
, pp. 22-32
-
-
Pimentel, M.1
Lembo, A.2
Chey, W.D.3
Zakko, S.4
Ringel, Y.5
Yu, J.6
-
135
-
-
0033636668
-
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
-
Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-6
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 3503-3506
-
-
Pimentel, M.1
Chow, E.J.2
Lin, H.C.3
-
136
-
-
41849111638
-
Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls
-
DOI 10.1111/j.1572-0241.2008.01785.x
-
Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008; 103:958-63 (Pubitemid 351501116)
-
(2008)
American Journal of Gastroenterology
, vol.103
, Issue.4
, pp. 958-963
-
-
Bratten, J.R.1
Spanier, J.2
Jones, M.P.3
-
137
-
-
0142244374
-
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROMEII criteria for irritable bowel syndrome
-
Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting the Rome II criteria for irritable bowel. World J Gastroenterol 2003;9:2293-9 (Pubitemid 37321463)
-
(2003)
World Journal of Gastroenterology
, vol.9
, Issue.10
, pp. 2293-2299
-
-
Portincasa, P.1
Moschetta, A.2
Baldassare, G.3
Altomare, D.F.4
Palasciano, G.5
-
138
-
-
78650874332
-
Antibiotic therapy for the irritable bowel syndrome
-
Tack J. Antibiotic therapy for the irritable bowel syndrome. N Engl J Med 2011;364:81-2
-
(2011)
N Engl J Med
, vol.364
, pp. 81-82
-
-
Tack, J.1
-
139
-
-
0001412472
-
Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis
-
Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44:854-9
-
(1958)
Surgery
, vol.44
, pp. 854-859
-
-
Eiseman, B.1
Silen, W.2
Bascom, G.S.3
Kauvar, A.J.4
-
140
-
-
80054736926
-
Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection
-
Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002
-
(2011)
Clin Infect Dis
, vol.53
, pp. 994-1002
-
-
Gough, E.1
Shaikh, H.2
Manges, A.R.3
-
141
-
-
84856969539
-
Fecal microbiota transplantation and emerging applications
-
Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012;9:88-96
-
(2012)
Nat Rev Gastroenterol Hepatol
, vol.9
, pp. 88-96
-
-
Borody, T.J.1
Khoruts, A.2
-
142
-
-
84871638124
-
Fecal microbiota transplantation: Past, present and future
-
Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: Past, present and future. Curr Opin Gastroenterol 2013;29: 79-84
-
(2013)
Curr Opin Gastroenterol
, vol.29
, pp. 79-84
-
-
Aroniadis, O.C.1
Brandt, L.J.2
-
143
-
-
0024970366
-
Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome?
-
Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, et al. Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989;150:604
-
(1989)
Med J Aust
, vol.150
, pp. 604
-
-
Borody, T.J.1
George, L.2
Andrews, P.3
Brandl, S.4
Noonan, S.5
Cole, P.6
-
144
-
-
3042511702
-
Bacteriotherapy using fecal flora: Toying with human motions
-
DOI 10.1097/01.mcg.0000128988.13808.dc
-
Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol 2004;38:475-83 (Pubitemid 38808419)
-
(2004)
Journal of Clinical Gastroenterology
, vol.38
, Issue.6
, pp. 475-483
-
-
Borody, T.J.1
Warren, E.F.2
Leis, S.M.3
Surace, R.4
Ashman, O.5
Siarakas, S.6
-
145
-
-
0034767063
-
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
-
DOI 10.1097/00042737-200110000-00004
-
Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001;13:1143-7 (Pubitemid 33015878)
-
(2001)
European Journal of Gastroenterology and Hepatology
, vol.13
, Issue.10
, pp. 1143-1147
-
-
Niedzielin, K.1
Kordecki, H.2
Birkenfeld, B.3
-
146
-
-
0036845692
-
Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome
-
DOI 10.1023/A:1020597001460
-
Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002;47:2615-20 (Pubitemid 35305475)
-
(2002)
Digestive Diseases and Sciences
, vol.47
, Issue.11
, pp. 2615-2620
-
-
Sen, S.1
Mullan, M.M.2
Parker, T.J.3
Woolner, J.T.4
Tarry, S.A.5
Hunter, J.O.6
|